Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same

Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same

US Patent 10716864 · Granted Jul 21, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies specific to human t-cell immunoglobulin and ITIM domain (TIGIT)2024
Antibodies specific to human t-cell immunoglobulin and ITIM domain (TIGIT)2024
Antibodies specific to human NECTIN42024
Antibodies specific to human NECTIN42024
Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)2021
Antibodies specific to human T-cell immunoglobulin and ITIM domain (TIGIT)2021
Attenuated or inactivated pathogenic Escherichia coli for treating urogenital ca2021
Antibodies specific to human poliovirus receptor (PVR)2021
Antibodies specific to human poliovirus receptor (PVR)2021
Vaccine comprising beta-herpesvirus2020
Method of treating type 1 diabetes by administering NKp46 polypeptide2015
Method of treating diabetes by administering an anti-NKp46 antibody2013